The Latest Scams from the Diabetic Industry

Updated January 31, 2017

Big Pharma and Big Medicine have faced many huge challenges over the past years to keep their cash cows—people with type-2 diabetes—each forking over an average of $13,700 annually (approximately 2.3 times more than what expenditures would be in the absence of diabetes). This financially rewarding system works well until the blood-sugar-lowering medicines, along with the gadgets and tests they rely on, are proven to be useless and dangerous. Unfortunately for the patients, industry fights back, defending their treasure-trove by hiring pricey medical experts, factoring in expected lawsuits, and exaggerating the benefits and minimizing the harms of their products.

Read More »